Top compounds associated with response to RPS9


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Doxorubicin gCSI pan-cancer AAC 0.26 2e-06
mRNA brivanib CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA tivozanib CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA Topotecan CTRPv2 pan-cancer AAC 0.16 1e-05
Download CSV